These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 8352552)

  • 21. Kinetics of methylmercury and inorganic mercury in lactating and nonlactating mice.
    Sundberg J; Jönsson S; Karlsson MO; Hallén IP; Oskarsson A
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):319-29. PubMed ID: 9707508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.
    Steinke W; Ahr HJ; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):939-48. PubMed ID: 9296280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NTP technical report on the toxicity studies of Cupric Sulfate (CAS No. 7758-99-8) Administered in Drinking Water and Feed to F344/N Rats and B6C3F1 Mice.
    Hebert C
    Toxic Rep Ser; 1993 Jul; 29():1-D3. PubMed ID: 12209195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase I and pharmacokinetic study of ILX-295501, an oral diarylsulfonylurea, on a weekly for 3 weeks every 4-week schedule in patients with advanced solid malignancies.
    Forouzesh B; Takimoto CH; Goetz A; Diab S; Hammond LA; Smetzer L; Schwartz G; Gazak R; Callaghan JT; Von Hoff DD; Rowinsky EK
    Clin Cancer Res; 2003 Nov; 9(15):5540-9. PubMed ID: 14654534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of radiolabelled quinlukast in rats.
    Syrovatko M; Laznickova A; Laznicek M
    J Pharm Biomed Anal; 2005 Jun; 38(2):313-9. PubMed ID: 15925224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignancies.
    Goss PE; Reid CL; Bailey D; Dennis JW
    Clin Cancer Res; 1997 Jul; 3(7):1077-86. PubMed ID: 9815786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of Large White Pig as an animal model for the study of cannabinoids metabolism: application to the study of THC distribution in tissues.
    Brunet B; Doucet C; Venisse N; Hauet T; Hébrard W; Papet Y; Mauco G; Mura P
    Forensic Sci Int; 2006 Sep; 161(2-3):169-74. PubMed ID: 16859848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
    Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice.
    Sauer JM; Bao J; Smith RL; Kuester RK; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Oct; 25(10):1184-90. PubMed ID: 9321522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inhibition effect of Swainsonine on the growth and metastasis of gastric cancer in vivo].
    Liu B; Lin Y; Yin H
    Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):168-70. PubMed ID: 10920997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats.
    Yoon WH; Park SJ; Kim IC; Lee MG
    Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):227-40. PubMed ID: 9226757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disposition of L-738,167, a potent and long-acting fibrinogen receptor antagonist, in dogs. Dose-dependent pharmacokinetics.
    Prueksaritanont T; Gorham LM; Naue JA; Hamill TG; Askew BC; Vyas KP
    Drug Metab Dispos; 1997 Mar; 25(3):355-61. PubMed ID: 9172954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and tissue distribution of Kendine 91, a novel histone deacetylase inhibitor, in mice.
    Otaegui D; Rodríguez-Gascón A; Zubia A; Cossío FP; Pedraz JL
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):153-9. PubMed ID: 19002463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced proliferation of functionally competent bone marrow cells in different strains of mice treated with swainsonine.
    Oredipe OA; Furbert-Harris PM; Laniyan I; Green WR; White SL; Olden K; Parish-Gause D; Vaughn T; Griffin WM; Sridhar R
    Int Immunopharmacol; 2003 Mar; 3(3):445-55. PubMed ID: 12639822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Swainsonine as a lysosomal toxin affects dopaminergic neurons.
    Li Q; Wang Y; Moldzio R; Lin W; Rausch WD
    J Neural Transm (Vienna); 2012 Dec; 119(12):1483-90. PubMed ID: 22729518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Swainsonine and endophyte relationships in Astragalus mollissimus and Astragalus lentiginosus.
    Cook D; Gardner DR; Grum D; Pfister JA; Ralphs MH; Welch KD; Green BT
    J Agric Food Chem; 2011 Feb; 59(4):1281-7. PubMed ID: 21214242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential degradation of swainsonine by intracellular enzymes of Arthrobacter sp. HW08.
    Wang Y; Li Y; Hu Y; Li J; Yang G; Kang D; Li H; Wang J
    Toxins (Basel); 2013 Nov; 5(11):2161-71. PubMed ID: 24240642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of intravenous cefmetazole with emphasis on comparison between predicted theoretical levels in tissue and actual skin window fluid levels.
    Tan JS; Salstrom SJ; Signs SA; Hoffman HE; File TM
    Antimicrob Agents Chemother; 1989 Jun; 33(6):924-7. PubMed ID: 2764542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.